Newsletter Subject

Editor's Pick: If you are between 12 and 14, get ready for a COVID jab

From

thehindu.com

Email Address

news@newsalertth.thehindu.com

Sent On

Tue, Mar 15, 2022 12:02 PM

Email Preheader Text

The Centre has decided to start COVID-19 vaccination for the 12-14 age group from March 16. In a rel

The Centre has decided to start COVID-19 vaccination for the 12-14 age group (those born between 2008 to 2010) from March 16. In a release issued on Monday, the Union Health Ministry said the decision was taken after due deliberations with scientific bodies. The vaccine to be administered would be Corbevax, manufactured by Biological E. Ltd., Hyderabad. Those above 14 years are already being administered COVID-19 vaccine. The announcement elicited mixed reaction from the medical fraternity. J.P. Muliyil, epidemiologist at CMC Vellore and a member of the working group of the National Technical Advisory Group on Immunisation (NTAGI) said there had to be tangible benefits from the vaccine. “In case of children, COVID-19 infection has so far proven to be non-serious and those infected have shown to have good natural immunity. Then there seems to be no logical reason for vaccinating children,” he said. The Omicron variant of COVID-19, which had infected a large section of the population, including children, seems to have passed on lasting natural immunity, he added. The Ministry has also decided that the condition of co-morbidity for COVID-19 precautions for the population aged over 60 will be removed from March 16. Union Health Minister Mansukh Mandaviya tweeted that if the children were safe, then the country was safe. He urged families to ensure the vaccination of children and those in the age group of 60 and above. That the report on vaccinating the young is the lead in the newspaper is indicative of the importance India is placing on vaccinating its people. The COVID pandemic is on a visible decline with the country reporting less than 6000 cases daily. Yet, we cannot let our guard down. As a recent editorial in The Hindu had pointed out, the question of supply is still very much up in the air and should the pandemic situation suddenly turn for a fourth wave, there would be a spike in demand for vaccinations for children, particularly those below 15, as well as booster doses for adults. Was this newsletter forwarded to you? Head over to our newsletter subscription page to sign up for Editor‘s Pick and more. Click here The Hindu’s Editorials The failed troika: On Congress’ CWC meeting A new deal: on reviving the JCPOA The Hindu’s Daily Quiz Indian embassy in Ukraine will be temporarily relocated to which country? Moldova Poland Romania Hungary To find out the answer and play the full quiz, click here [logo] Editor's Pick 15 MARCH 2022 [The Hindu logo] In the Editor's Pick newsletter, The Hindu explains why a story was important enough to be carried on the front page of today's edition of our newspaper. [Arrow]( [Open in browser]( [Mail icon]( [More newsletters]( If you are between 12 and 14, get ready for a COVID jab The Centre has decided to start [COVID-19 vaccination for the 12-14 age group]( (those born between 2008 to 2010) from March 16. In a release issued on Monday, the Union Health Ministry said the decision was taken after due deliberations with scientific bodies. The vaccine to be administered would be Corbevax, manufactured by Biological E. Ltd., Hyderabad. Those above 14 years are already being administered COVID-19 vaccine. The announcement elicited mixed reaction from the medical fraternity. J.P. Muliyil, epidemiologist at CMC Vellore and a member of the working group of the National Technical Advisory Group on Immunisation (NTAGI) said there had to be tangible benefits from the vaccine. “In case of children, COVID-19 infection has so far proven to be non-serious and those infected have shown to have good natural immunity. Then there seems to be no logical reason for vaccinating children,” he said. The Omicron variant of COVID-19, which had infected a large section of the population, including children, seems to have passed on lasting natural immunity, he added. The Ministry has also decided that the condition of co-morbidity for COVID-19 precautions for the population aged over 60 will be removed from March 16. Union Health Minister Mansukh Mandaviya tweeted that if the children were safe, then the country was safe. He urged families to ensure the vaccination of children and those in the age group of 60 and above. That the report on vaccinating the young is the lead in the newspaper is indicative of the importance India is placing on vaccinating its people. The COVID pandemic is on a visible decline with the country reporting less than 6000 cases daily. Yet, we cannot let our guard down. As a recent editorial in The Hindu had pointed out, the question of supply is still very much up in the air and should the pandemic situation suddenly turn for a fourth wave, there would be a spike in demand for vaccinations for children, particularly those below 15, as well as booster doses for adults. Was this newsletter forwarded to you? Head over to our newsletter subscription page to sign up for Editor‘s Pick and more.  [Click here]( The Hindu’s Editorials [Arrow][The failed troika: On Congress’ CWC meeting](  [Arrow][A new deal: on reviving the JCPOA]( The Hindu’s Daily Quiz Indian embassy in Ukraine will be temporarily relocated to which country? - Moldova - Poland - Romania - Hungary To find out the answer and play the full quiz, [click here]( Today’s Best Reads [[Impact of Assembly Election results | Talking Politics With Nistula Hebbar] Impact of Assembly Election results | Talking Politics With Nistula Hebbar]( [[Anti-war protester in studio interrupts live Russian news broadcast] Anti-war protester in studio interrupts live Russian news broadcast]( [[Auschwitz survivor Leon Schwarzbaum dies aged 101 in Germany] Auschwitz survivor Leon Schwarzbaum dies aged 101 in Germany]( [[Centre launches ₹19,000 cr. river afforestation plan] Centre launches ₹19,000 cr. river afforestation plan]( Copyright @ 2022, THG PUBLISHING PVT LTD. If you are facing any trouble in viewing this newsletter, please [try here]( If you do not wish to receive such emails [go here](

Marketing emails from thehindu.com

View More
Sent On

08/12/2024

Sent On

08/12/2024

Sent On

08/12/2024

Sent On

07/12/2024

Sent On

05/12/2024

Sent On

05/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.